Nordhealth Valuation

Is NORDH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NORDH?

Other financial metrics that can be useful for relative valuation.

NORDH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.4x
Enterprise Value/EBITDA-23.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does NORDH's PS Ratio compare to its peers?

The above table shows the PS ratio for NORDH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average2.9x
CARA Carasent
4.7x14.7%kr1.1b
CSAM CSAM Health Group
1.8x7.6%kr703.0m
CONTX ContextVision
4.5x6.3%kr564.8m
CODE CodeLab Capital
0.8xn/akr119.3m
NORDH Nordhealth
5.2xn/akr2.1b

Price-To-Sales vs Peers: NORDH is expensive based on its Price-To-Sales Ratio (5.2x) compared to the peer average (2.9x).


Price to Earnings Ratio vs Industry

How does NORDH's PE Ratio compare vs other companies in the European Healthcare Services Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a24.7%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a24.7%
n/an/an/a
No more companies

Price-To-Sales vs Industry: NORDH is expensive based on its Price-To-Sales Ratio (5.2x) compared to the European Healthcare Services industry average (3x).


Price to Sales Ratio vs Fair Ratio

What is NORDH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NORDH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate NORDH's Price-To-Sales Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of NORDH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NORDH's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NORDH's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies